Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study). (Q46850739)

25 December 2017

title

Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study). (English)

1 reference

25 December 2017

1 reference

Emmanuel Haffen

29

0 references

Frédéric Haesebaert

Frédéric Haesebaert

13

0 references

Wissam El-Hage

Wissam El-Hage

11

0 references

Philippe Le Corvoisier

Philippe Le Corvoisier

21

0 references

Marion Leboyer

Marion Leboyer

17

0 references

Thomas Desmidt

Thomas Desmidt

12

0 references

Frank Bellivier

30

Frank Bellivier

1 reference

25 December 2017

10

Pierre-Michel Llorca

1 reference

25 December 2017

Jean-Luc Cracowski

16

Jean-Luc Cracowski

1 reference

25 December 2017

Liova Yon

20

Liova Yon

1 reference

25 December 2017

Raphaëlle Richieri

8

Raphaëlle-Marie Richieri

1 reference

25 December 2017

Antoine Yrondi

18

Antoine Yrondi

1 reference

25 December 2017

author name string

Célia Lloret-Linares

1

1 reference

25 December 2017

Youssef Daali

2

1 reference

25 December 2017

Sylvie Chevret

3

1 reference

25 December 2017

Isabelle Nieto

4

1 reference

25 December 2017

Fanny Molière

5

1 reference

25 December 2017

Philippe Courtet

6

1 reference

25 December 2017

Florence Galtier

7

1 reference

25 December 2017

Sophie Morange

9

1 reference

25 December 2017

Philippe Vignaud

14

1 reference

25 December 2017

Jerôme Holtzmann

15

1 reference

25 December 2017

Fabienne Calvas

19

1 reference

25 December 2017

Olivier Doumy

22

1 reference

25 December 2017

Kyle Heron

23

1 reference

25 December 2017

Damien Montange

24

1 reference

25 December 2017

Siamak Davani

25

1 reference

25 December 2017

Julien Déglon

26

1 reference

25 December 2017

Marie Besson

27

1 reference

25 December 2017

Jules Desmeules

28

1 reference

25 December 2017

publication date

7 November 2017

1 reference

25 December 2017

BMC pharmacology & toxicology

published in

1 reference

25 December 2017

volume

18

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

70

1 reference

25 December 2017

Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant Prescription

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

New microfluidic-based sampling procedure for overcoming the hematocrit problem associated with dried blood spot analysis

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

PharmGKB summary: venlafaxine pathway

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Applications of CYP450 testing in the clinical setting

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Using a pharmacogenomic algorithm to guide the treatment of depression

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Personalized medicine in major depressive disorder -- opportunities and pitfalls

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Cytochrome P450 variations in different ethnic populations

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Cost of disorders of the brain in Europe 2010.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Adverse reactions to antidepressants

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA).

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Cost of depression in Europe

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

"Cocktail" approaches and strategies in drug development: valuable tool or flawed science?

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

The impact of treatment-resistant depression on health care utilization and costs

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Venlafaxine extended-release: a review of its use in the management of major depression

24 May 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

24 May 2018

https://api.crossref.org/works/10.1186/S40360-017-0173-2

New strategies for treating chronic depression

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Venlafaxine serum levels and CYP2D6 genotype

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Treatment resistant depression: methodological overview and operational criteria

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

A poor metabolizer of both CYP2C19 and CYP2D6 identified by mechanistic pharmacokinetic simulation in a fatal drug poisoning case involving venlafaxine

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

The impact of diabetes on depression treatment outcomes

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Genotype???phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Sustained response to open-label venlafaxine in drug-resistant major depression

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5678760

Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine

15 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186/S40360-017-0173-2

Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite

21 January 2018

1 reference

12 December 2020

[Tyrer's Brief Scale for Anxiety used with outpatients. First validation in the French language]

1 reference

12 December 2020

Polymorphic debrisoquin hydroxylation in 757 Swedish subjects

1 reference

12 December 2020

Defining remission by cut off score on the MADRS: selecting the optimal value

1 reference

12 December 2020

10.1186/S40360-017-0173-2

Identifiers

DOI

1 reference

25 December 2017

Dimensions Publication ID

0 references

1 reference

25 December 2017

PubMed publication ID

29115994

1 reference

25 December 2017